ICER Debuts Clinical Trial Diversity Assessment Framework

 
• By Sue Sutter
  
House frame
ICER has developed a framework for assessing clinical trial diversity. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

More from Clinical Trials